Markóczy Zsolt; Sárosi Veronika; Kudaba Iveta; Gálffy Gabriella; Turay Ülkü Yilmaz; Demirkazik Ahmet; Purkalne Gunta; Somfay Attila; Pápai-Székely Zsolt; Rásó Erzsébet; Ostoros Gyula:
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC CANCER, 18 (1).
Azonosító: 598-Terjedelem: 7 p.
ISSN 1471-2407
(2018)